Neoplasms

All Conditions

Rare Diseases

Sarcoma

Neoplasms, Connective and Soft Tissue

Neoplasms by Histologic Type

Soft Tissue Sarcoma

All Drugs and Chemicals

Immunomodulating Agents

Immunologic Factors

Chemotherapy

Immunotherapeutic Agent

target treatment

Surgery

Radiotherapy

Maud Toulmonde, MD

Simone Mathoulin-Pélissier, MD/PhD

Antoine Italiano, MD/PhD

Jean-Yves Blay, MD/PhD

Axel Le Cesne, MD/PhD

The BCB SARCOMES database is a clinical and biological national database dedicated to sarcoma that contains 3 main databases with specific aims: the first is the pathology database (French expert network dedicated to the management of bone sarcomas \[RESOS\] / French expert network dedicated to the pathology of sarcomas \[RREPS\]), dedicated to systematic review of mesenchymal tumor diagnostics nationwide; the second is clinical (RESOS / French expert clinical network for sarcomas \[NETSARC\]), collecting multidisciplinary tumor boards (MDTB) data of patients nationwide, and the third (CONTICABASE / BONE / GIST) is dedicated to collecting patients longitudinal/follow up data, with a focus on treatments of every events, and a catalogue of associated samples.

Primary objectives of BCB-SARCOMES are the following: description of the patterns of care and treatment outcomes, assessment of the prognostic factors of patients' outcomes.

With the financial support of the French National Cancer Institute \[Institut National du cancer \[INCa\]).

National Clinical and Biological Sarcoma Database : An Initiative of the French Sarcoma Group

The "BCB-sarcomes" Database: the Database of the French Sarcoma Group Dedicated to the Collection of Clinical and Biological Data for All Sarcomas

Time from the systemic treatment onset to the next treatment or death due to any cause, whichever comes first. When neither death nor new systemic therapy is observed, TNT is censored at the date of last patient contact.

Interval between diagnosis and the time of death. When death is not observed, OS is censored at the date of last patient contact.

French Sarcoma Group

Institut Bergonié

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization	Link
National Clinical and Biological Sarcoma Database : An Initiative of the French Sarcoma Group	NCT03978039	Sarcoma	Chemotherapy Immunotherapeut... target treatmen... Surgery Radiotherapy	-	Institut Bergonié
National Clinical and Biological Sarcoma Database : An Initiative of the French Sarcoma Group	NCT03978039	Sarcoma	Chemotherapy Immunotherapeut... target treatmen... Surgery Radiotherapy	-	Institut Bergonié

Spots Global Cancer Trial Database for target treatment